Home › NDC Lookup › RxCUI directory › RxCUI 602427

Clindamycin 20 MG/ML Vaginal Cream [Clindesse] — RxCUI 602427

RxNorm drug concept · Semantic branded drug
RxCUI 602427 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI602427
Official nameClindamycin 20 MG/ML Vaginal Cream [Clindesse]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asClindesse 2 % Vaginal Cream; Clindesse (as clindamycin phosphate) 2 % Vaginal Cream; Clindesse 20 MG/ML Vaginal Cream
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,843 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clindamycin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Bacterial vaginosis (BV) is not a sexually transmitted infection in the traditional sense — it's an overgrowth of certain bacteria that naturally live in the vagina, causing an imb...
  • What is the vaginal cream actually treating — is bacterial vaginosis an STI?
  • No — and this is really important. The Clindesse vaginal cream contains mineral oil, which can break down latex. That means condoms and diaphragms may not protect you from pregnanc...
  • Can I use a condom or diaphragm while using the vaginal cream?
📖 Read our full Clindamycin Topical guide →

🕸️ Concept Web — How Clindamycin 20 MG/ML Vaginal Cream [Clindesse] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Clindamycin 20 MG/ML Vaginal Cream [Clindesse] RxCUI 602427

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Clindamycin 2582
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Clindesse 496585
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clindamycin Vaginal Cream 377651
    • Clindamycin Vaginal Product 1152789
    • Clindamycin Vaginal Cream [Clindesse] 602426
    • Clindesse Vaginal Product 1172356
    • Vaginal Cream 11103
    • Vaginal Product 1151125
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clindamycin 20 MG/ML Vaginal Cream SCD · 309337
  • Clindamycin 20 MG/ML SCDC · 343114
  • Clindamycin Vaginal Cream SCDF · 377651
  • Clindamycin Vaginal Product SCDG · 1152789

Brand-Name Concepts

  • Clindamycin 20 MG/ML [Clindesse] SBDC · 602425
  • Clindamycin Vaginal Cream [Clindesse] SBDF · 602426
  • Clindesse Vaginal Product SBDG · 1172356
  • Clindesse BN · 496585

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 602427 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
45802-0042-01 1 APPLICATOR in 1 CARTON (45802-042-01) / 5 g in 1 APPLICAT... Clindesse Padagis Israel Pharmaceuticals Ltd 2015-07-03
45802-0042-02 1 APPLICATOR in 1 CARTON (45802-042-02) / 5 g in 1 APPLICAT... Clindesse Padagis Israel Pharmaceuticals Ltd 2015-07-03
Observed labelers: Padagis Israel Pharmaceuticals Ltd (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$26.6332
Range $26.6332–$26.6332 · middle 50% $26.6332–$26.6332 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.